SCHEMBL4956601

SCHEMBL4956601

CC(C)(CC(=O)N(CCc1ccccc1)Cc1ccccc1)C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CA12 O43570 11/20 0.49
CA1 P00915 11/20 0.49
CA2 P00918 11/20 0.49
CA4 P22748 5/20 0.49
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
HTT P42858 1/20 0.47
RCE1 Q9Y256 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28746888 0.83 KMT2A (0.50) CA12CA1CA2CA4KMT2A
SCHEMBL12018645 0.80 L3MBTL1 (0.49) CA12CA1CA2CA4KMT2A
SCHEMBL3422890 0.77 MEN1 (0.56) CA12CA1CA2CA4KMT2A
SCHEMBL4956597 0.77 RCE1 (0.45) CA12CA1CA2CA4KMT2A
SCHEMBL7228409 0.75 MEN1 (0.61) CA12CA1CA2CA4KMT2A
SCHEMBL28208793 0.74 LMNA (0.51) KMT2ANPC1RAB9ATDP1
SCHEMBL2186353 0.74 RCE1 (0.56) CA12CA1CA2CA4KMT2A
SCHEMBL6803588 0.73 HDAC3 (0.50) KMT2AMEN1NPC1RAB9AL3MBTL1
SCHEMBL9823156 0.72 HDAC1 (0.54) KMT2AMEN1NPC1RAB9ATDP1
SCHEMBL27478411 0.72 LTB4R (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7323448-B2 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2008-01-29 US disclosed
US-7148198-B2 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS, LTD. (GB) 2006-12-12 US disclosed
US-20060276409-A1 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2006-12-07 US disclosed
US-20050014702-A1 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2005-01-20 US disclosed
US-6787522-B2 BACTERIAL POLYPEPTIDE DEFORMYLASE (PDF) INHIBITORS, N-FORMYL HYDROXYLAMINE DERIVATIVES BRITISH BIOTECH PHARMACEUTICALS (GB) 2004-09-07 US disclosed
EP-1052984-B1 ANTIBACTERIAL AGENTS VERNALIS OXFORD LTD (GB) 2004-05-12 EP disclosed
US-20020165167-A1 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2002-11-07 US disclosed
US-6423690-B1 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2002-07-23 US disclosed
EP-1052984-A1 ANTIBACTERIAL AGENTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2000-11-22 EP disclosed
WO-1999039704-A1 ANTIBACTERIAL AGENTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1999-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276409-A1 Antibacterial agents CBR3, CBR1, SIGMAR1 CA12 1844/4885CA1 2202/4885CA2 1194/4885
US-20050014702-A1 Antibacterial agents CBR3, CBR1, SIGMAR1 CA12 1844/4885CA1 2202/4885CA2 1194/4885
US-20020165167-A1 Antibacterial agents CBR1, CBR3, SIGMAR1 CA12 2688/4885CA1 2698/4885CA2 754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.